Optogenetics shows promise in improving mobility and object recognition for patients with retinitis pigmentosa and Stargardt disease.
Stephen Tsang, MD, PhD
Advertisement
Professor at Columbia University and attending physician at NewYork-Presbyterian Hospital
Articles by Stephen Tsang, MD, PhD
Advertisement
Latest Updated Articles
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseasesPublished: October 22nd 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
Retina experts reflect on how OCT transformed patient care
4
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
5
.png "Optometry Times"){kind=logo}
